Studies have revealed that the drug also inhibits
bacterial efflux pumps that permit bacteria to survive within cells.
Bacterial efflux pumps, such as the P. aeruginosa MexAB - OprM pump shown here, are one of the dominant molecular mechanisms available to Gram - negative pathogens for removing toxins, including antibiotics.
They plan to leverage a recently awarded Innovative and Novel Computational Impact on Theory and Experiment (INCITE) allocation from DOE to perform larger simulations on the Titan supercomputer to gain deeper understanding of how
bacterial efflux pumps function, identify more potent efflux pump inhibitors and optimize the best antibiotic - plus - inhibitor combinations to make them suitable for clinical trials.
Not exact matches
The UTSW experiment focused on Escherichia coli (E. coli) and
bacterial pathogens with genetically similar
efflux pump complexes.
Some coded for multi-drug
efflux pumps, which are multi-drug resistance mechanisms embedded in the
bacterial membrane that
pump specific antibiotics out of the bacteria.
Heterogeneity in a
bacterial population that arises through a mechanism of biased partitioning of drug
efflux pumps, as we identified in our study, could be a stepping - stone on the path of
bacterial populations towards antibiotic resistance.»
The team focused on one
efflux pump protein, known as AcrA, which connects two other proteins in a tunnel shape through the
bacterial cell envelope.
The researchers found four new chemicals that seek out and disrupt
bacterial proteins called «
efflux pumps,» known to be a major cause of antibiotic resistance.
Efflux pumps are surface proteins that prevent antimicrobial drugs from getting a foothold in a
bacterial cell by identifying and
pumping them out of the cell.